Related references
Note: Only part of the references are listed.A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics
Priya U. Kumthekar et al.
NEURO-ONCOLOGY (2023)
Leptomeningeal metastases: the future is now
Rimas V. Lukas et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis
Jonathan T. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR-mutation non-small cell lung cancer: A phase II single-arm prospective clinical trial
Zhi-qin Lu et al.
THORACIC CANCER (2021)
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
Priscilla K. Brastianos et al.
NATURE COMMUNICATIONS (2021)
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC-a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615)
Chengjuan Fan et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer
Emilie Le Rhun et al.
NEURO-ONCOLOGY (2020)
Leptomeningeal metastasis from solid tumors
Jigisha P. Thakkar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Priscilla K. Brastianos et al.
NATURE MEDICINE (2020)
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
Rachna Malani et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis
Yudan Chi et al.
SCIENCE (2020)
Complications associated with intrathecal drug delivery systems
E. M. Delhaas et al.
BJA EDUCATION (2020)
Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer
Maciej M. Mrugala et al.
CLINICAL BREAST CANCER (2019)
Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients
Diana M. Byrnes et al.
JOURNAL OF ONCOLOGY (2019)
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
Claire Bonneau et al.
EUROPEAN JOURNAL OF CANCER (2018)
The Comparative Treatment of lntraventricular Chemotherapy by Ommaya Reservoir vs. Lumbar Puncture in Patients With Leptomeningeal Carcinomatosis
Mariano Montes de Oca Delgado et al.
FRONTIERS IN ONCOLOGY (2018)
Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study
Zhenyu Pan et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study
Ho-Shin Gwak et al.
ONCOLOGIST (2014)
Ventriculolumbar Perfusion Chemotherapy for the Treatment of Leptomeningeal Carcinomatosis A Phase I Study With Pharmacokinetic Data
Ho-Shin Gwak et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Survival of breast cancer patients with meningeal carcinomatosis
H. Gauthier et al.
ANNALS OF ONCOLOGY (2010)
Route of Intracerebrospinal Fluid Chemotherapy Administration and Efficacy of Therapy in Neoplastic Meningitis
Michael J. Glantz et al.
CANCER (2010)
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
Patrick Beauchesne
LANCET ONCOLOGY (2010)
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D. Groves et al.
NEURO-ONCOLOGY (2008)
Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors
Nobusada Shinoura et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis
Ronald J. Bernardi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Phase I study of targeted Radioimmunotherapy for leptomeningeal cancers using intra-ommaya 131-I-3F8
Kim Kramer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Breast cancer leptomeningeal metastasis - the role of multimodality treatment
Halina Rudnicka et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt (R)) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study
Surasak Phuphanich et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Continuous intrathecal administration of 5-fluoro-2′-deoxyuridine for the treatment of neoplastic meningitis
H Nakagawa et al.
NEUROSURGERY (2005)
Intrathecal mafosfamide: A preclinical pharmacology and phase I trial
SM Blaney et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study
W Boogerd et al.
EUROPEAN JOURNAL OF CANCER (2004)
Ouality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis
BF Cole et al.
CANCER (2003)
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis
SM Blaney et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An open label trial of sustained-release cytarabine (DepoCyt™) for the intrathecal treatment of solid tumor neoplastic meningitis
KA Jaeckle et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Intracavitary chemotherapy with 5-fluoro-2′-deoxyuridine (FdUrd) in malignant brain tumors
H Nakagawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
KA Jaeckle et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
